{"id":1063538,"date":"2013-08-30T11:44:00","date_gmt":"2013-08-30T15:44:00","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/stem-cells\/tracking-the-fruits-of-california-stem-cell-agency-research.php"},"modified":"2024-08-17T20:30:22","modified_gmt":"2024-08-18T00:30:22","slug":"tracking-the-fruits-of-california-stem-cell-agency-research","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/tracking-the-fruits-of-california-stem-cell-agency-research.php","title":{"rendered":"Tracking the Fruits of California Stem Cell Agency Research"},"content":{"rendered":"<div><span>The California stem<br>cell agency yesterday shed some interesting light on the awards in its $41<br>million round this week and their pathway to actually producing a product that<br>can be used to treat persons who are suffering from diseases.<\/span><\/div><div><span><br><\/span><\/div><div><span><span>It is a difficult and<br>long journey to generate usable therapies, a process poorly understood by the<br>public, which was promised in 2004 that the stem cell agency would produce<br>cures for ailments afflicting half the population of the state. <\/span><\/span><\/div><div><span><span><br><\/span><\/span><\/div><div><span><span><a href=\"http:\/\/cirmresearch.blogspot.com\/2013\/08\/40-million-for-new-awards-to-target.html\" target=\"_blank\" rel=\"noopener\">Writing on the agency&rsquo;s blog<\/a>, <b>Amy Adams, CIRM<\/b> communications manager, dealt with the issue indirectly.<br>She said,<\/span><\/span><\/div><blockquote><p><span><span>&ldquo;Many scientists who<br>receive our early translation awards first got their idea for a therapy while<br>carrying out research with one of our other awards. In fact, eight of the<br>scientists in this round of funding had previous CIRM funding for an earlier<br>stage of research. If a scientist's early translation award provides good<br>results, the scientists are then able to apply for one of our disease team<br>awards, which fund the effort of compiling data to convince the <b>Food and Drug<br>Administration <\/b>to allow them to test it in people.&nbsp; Other organizations<br>fund only early discovery research or only preclinical research. Under those<br>conditions, researchers continually pause their projects to look for new<br>sources of funding as the project moves through the phases toward clinical<br>trial.<\/span>&rdquo;<\/span><\/p><\/blockquote><div><span><span>One of the virtues of<br>the California stem cell agency is its promise of a continued stream of<br>funding. Former Chairman <b>Robert Klein<\/b> used to tout that particular aspect of<br>the agency, particularly in light of limited federal resources. <\/span><\/span><\/div><div><span><span><br><\/span><\/span><\/div><div><span><span>Adams&rsquo; comments<br>implicitly raise important questions concerning CIRM&rsquo;s entire portfolio. How<br>many CIRM grants have led to additional funding from CIRM? How many are<br>basically one-off shots that have not led to research that has advanced the<br>development of stem cell therapies, either via CIRM or other funding. What is the<br>therapeutic and scientific significance of the research that is linked by more<br>than one CIRM award? &nbsp;What previously<br>funded CIRM research could be fruitfully funded again to advance the science<br>and not necessarily through the traditional grant rounds, which sometimes have<br>awkward timing?<\/span><\/span><\/div><div><span><span><br><\/span><\/span><\/div><div><span><span>Unmentioned in Adams&rsquo;<br>item is an application from a <b>UC Irvine<\/b> researcher that came up at Wednesday&rsquo;s<br>meeting of the governing board of the stem cell agency. The woman, whose name<br>was not clearly audible on the Internet audiocast, publicly appealed rejection<br>of her application by reviewers. She noted that it was an extension of work<br>that was previously funded by the agency. She also noted that the score on her<br>review was all but identical to work that was funded. The board, however,<br>turned her appeal aside, which had already been rejected behind closed doors by<br>CIRM staff.<\/span><\/span><\/div><p><\/p><div><span><span>Hers is not the only<br>such case in CIRM history. But they are virtually impossible to track systematically<br>because of the structure of the CIRM grant-making progress. It is also not<br>clear whether the agency itself is tracking its research awards to determine if<br>they result in continuing, fruitful research in a specific area. Nonetheless,<br>the matter deserves some public attention.&nbsp;<\/span><span><\/span><\/span><\/div><p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/www.longevitymedicine.tv\/wp-content\/plugins\/wp-o-matic\/cache\/f575d8b107_iPivfY1LHPk.\" height=\"1\" width=\"1\" style=\"padding-left:10px; padding-right: 10px;\">Source:<br><a href=\"http:\/\/feedproxy.google.com\/~r\/blogspot\/uqpFc\/~3\/iPivfY1LHPk\/tracking-fruits-of-california-stem-cell.html\">http:\/\/feedproxy.google.com\/~r\/blogspot\/uqpFc\/~3\/iPivfY1LHPk\/tracking-fruits-of-california-stem-cell.html<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The California stemcell agency yesterday shed some interesting light on the awards in its $41million round this week and their pathway to actually producing a product thatcan be used to treat persons who are suffering from diseases.It is a difficult &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/tracking-the-fruits-of-california-stem-cell-agency-research.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25,1246878],"tags":[],"class_list":["post-1063538","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy","category-stem-cells"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063538"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1063538"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063538\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1063538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1063538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1063538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}